Evidence map›Paper›PMID 28158188›Full record

ArticlePLoS neglected tropical diseases2017

DNA multigene characterization of Fasciola hepatica and Lymnaea neotropica and its fascioliasis transmission capacity in Uruguay, with historical correlation, human report review and infection risk analysis.

María Dolores Bargues, Valeria Gayo, Jaime Sanchis, Patricio Artigas, Messaoud Khoubbane, Soledad Birriel, Santiago Mas-Coma

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Fascioliasis.Advances in experimental medicine and biology · 2024
    Article
  12. Article
  13. Article
  14. Geographical Influence on Morphometric Variability of Genetically "Pure"Tropical medicine and infectious disease · 2023
    Article
  15. Molecular characterization ofFrontiers in veterinary science · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Paleobiogeographical origins ofFrontiers in veterinary science · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

María Dolores BarguesDepartamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain.ORCID 0000-0003-2347-7269
Valeria GayoDepartamento de Parasitología, División de Laboratorios Veterinarios (DILAVE), "Miguel C. Rubino", Ministerio de Ganadería, Agricultura y Pesca (MGAP), Montevideo, Uruguay.
Jaime SanchisDepartamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain.
Patricio ArtigasDepartamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain.
Messaoud KhoubbaneDepartamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain.
Soledad BirrielFacultad de Veterinaria, Universidad de la República Oriental del Uruguay, Montevideo, Uruguay.
Santiago Mas-ComaDepartamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain.
Universitat de València · ESMinisterio de Ganadería Agricultura y Pesca · UYUniversidad de la República de Uruguay · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFascioliasis is a pathogenic disease transmitted by lymnaeid snails and recently emerging in humans, in part due to effects of climate changes, anthropogenic environment modifications, import/export and movements of livestock. South America is the continent presenting more human fascioliasis hyperendemic areas and the highest prevalences and intensities known. These scenarios appear mainly linked to altitude areas in Andean countries, whereas lowland areas of non-Andean countries, such as Uruguay, only show sporadic human cases or outbreaks. A study including DNA marker sequencing of fasciolids and lymnaeids, an experimental study of the life cycle in Uruguay, and a review of human fascioliasis in Uruguay, are performed. METHODOLOGY/PRINCIPAL

findingsThe characterization of Fasciola hepatica from cattle and horses of Uruguay included the complete sequences of the ribosomal DNA ITS-2 and ITS-1 and mitochondrial DNA cox1 and nad1. ITS-2, ITS-1, partial cox1 and rDNA 16S gene of mtDNA were used for lymnaeids. Results indicated that vectors belong to Lymnaea neotropica instead of to Lymnaea viator, as always reported from Uruguay. The life cycle and transmission features of F. hepatica by L. neotropica of Uruguay were studied under standardized experimental conditions to enable a comparison with the transmission capacity of F. hepatica by Galba truncatula at very high altitude in Bolivia. On this baseline, we reviewed the 95 human fascioliasis cases reported in Uruguay and analyzed the risk of human infection in front of future climate change estimations. CONCLUSIONS/SIGNIFICANCE: The correlation of fasciolid and lymnaeid haplotypes with historical data on the introduction and spread of livestock into Uruguay allowed to understand the molecular diversity detected. Although Uruguayan L. neotropica is a highly efficient vector, its transmission capacity is markedly lower than that of Bolivian G. truncatula. This allows to understand the transmission and epidemiological differences between Andean highlands and non-Andean lowlands in South America. Despite rainfall increase predictions for Uruguay, nothing suggests a trend towards a worrying human infection scenario as in Andean areas.

Indexed as

Genetic VariationAcanthaceaeAnimalsCattleCluster AnalysisDNA, HelminthDNA, RibosomalDNA, Ribosomal SpacerFasciola hepaticaFascioliasisGenotypeHorsesHumansPhylogenyRisk AssessmentRNA, Ribosomal, 16SDNA, HelminthDNA, RibosomalDNA, Ribosomal SpacerRNA, Ribosomal, 16S

Identifiers

PMID28158188
PMCPMC5310921
OpenAlexW2583401051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.